GLP-1 has been shown to decrease calorie intake in animal models by intracerebroventricular and hypothalamic paraventricular nucleus (PVN) administration.34 An infusion of OXM to normal-weight human subjects produced a reduction in calorie intake of 19.3%, whereas a recent meta-analysis which studied the effect of GLP-1 infusion demonstrated an average reduction in calorie intake of 11.7%
It contains elevated levels of zinc, copper, magnesium, and chromium to support normal insulin sensitivity, hoof integrity, and antioxidant defense
If you're looking to start MIC B12 therapy, it's important to work with a healthcare provider who can tailor the treatment to your personal needs
A proper GLP-1 assessment may include weight history, prior treatment, medications, eating behavior, gastrointestinal symptoms, pregnancy plans, gallbladder or pancreatic history, kidney function, metabolic risk, contraindications, and a plan for side effects and follow-up